Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Busca A, Candoni A, Audisio E, Passera R, Bruno B, Monaco F, Mordini N, Vacca A, Delia M, Aversa F, Pagano L. Busca A, et al. Among authors: mordini n. Biol Blood Marrow Transplant. 2016 Dec;22(12):2214-2219. doi: 10.1016/j.bbmt.2016.09.019. Epub 2016 Sep 22. Biol Blood Marrow Transplant. 2016. PMID: 27667012 Free article.
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.
Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, Lamparelli T, Occhini D, Mordini N, Bregante S, Figari O, Benvenuto F, Sessarego M, Fugazza G, Carlier P, Valbonesi M. Bacigalupo A, et al. Among authors: mordini n. Bone Marrow Transplant. 1997 May;19(9):927-32. doi: 10.1038/sj.bmt.1700762. Bone Marrow Transplant. 1997. PMID: 9156268 Clinical Trial.
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Zikos P, Van Lint MT, Frassoni F, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, De Stefano F, Soracco M, Vitale V, Bacigalupo A. Zikos P, et al. Among authors: mordini n. Blood. 1998 May 1;91(9):3503-8. Blood. 1998. PMID: 9558411 Free article. Clinical Trial.
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
Moretti S, Zikos P, Van Lint MT, Tedone E, Occhini D, Gualandi F, Lamparelli T, Mordini N, Berisso G, Bregante S, Bruno B, Bacigalupo A. Moretti S, et al. Among authors: mordini n. Bone Marrow Transplant. 1998 Jul;22(2):175-80. doi: 10.1038/sj.bmt.1701302. Bone Marrow Transplant. 1998. PMID: 9707026 Clinical Trial.
Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.
Bacigalupo A, Oneto R, Bruno B, Soracco M, Lamparelli T, Gualandi F, Occhini D, Raiola A, Mordini N, Berisso G, Bregante S, Dini G, Lombardi A, Lint MV, Brand R. Bacigalupo A, et al. Among authors: mordini n. Bone Marrow Transplant. 1999 Sep;24(6):653-9. doi: 10.1038/sj.bmt.1701953. Bone Marrow Transplant. 1999. PMID: 10490732
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
Bregante S, Bertilson S, Tedone E, Van Lint MT, Trespi G, Mordini N, Berisso G, Gualandi F, Lamparelli T, Figari O, Benvenuto F, Raiola AM, Bacigalupo A. Bregante S, et al. Among authors: mordini n. Bone Marrow Transplant. 2000 Jul;26(1):23-9. doi: 10.1038/sj.bmt.1702450. Bone Marrow Transplant. 2000. PMID: 10918402 Clinical Trial.
74 results